Company / Free Cash Flow per Share
Krystal Biotech, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$6.56
FY2025
5-year range
-$6.02 / $6.56
FY2021-FY2025
Trend
+55.4%
vs FY2024
Sector context
#15 of 192
Health Care
What the data says
Among 192 Health Care companies, Krystal Biotech, Inc. is in the top 8% for free cash flow per share. Free Cash Flow per Share has increased for 3 consecutive years, from $-6.02 in FY2022 to $6.56 in FY2025.
Based on SEC 10-K filings.
6.56 in FY2025. Top quartile in the Health Care sector.
Improved from $-3.90 to $6.56 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 192This company $6.56 Sector average -$19.84
▼
+133.1% above sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 55.4% year-over-year.
- Ranks #15 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.56 | +55.4% |
| FY2024 | $4.22 | +208.1% |
| FY2023 | -$3.90 | +35.2% |
| FY2022 | -$6.02 | -15.0% |
| FY2021 | -$5.24 | -140.5% |
| FY2020 | -$2.18 | -38.1% |
| FY2019 | -$1.58 | -51.4% |
| FY2018 | -$1.04 | -36.3% |
| FY2017 | -$0.76 | +49.4% |
| FY2016 | -$1.51 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026